Balance Sheet
Cash Flow Statement
AmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics (PRQR) Change in Taxes (2017 - 2025)

ProQR Therapeutics' Change in Taxes history spans 5 years, with the latest figure at $43069.6 for Q4 2025.

  • On a quarterly basis, Change in Taxes rose 110.23% to $43069.6 in Q4 2025 year-over-year; TTM through Dec 2025 was -$398332.3, a 90.67% decrease, with the full-year FY2025 number at $22116.8, up 110.51% from a year prior.
  • Change in Taxes hit $43069.6 in Q4 2025 for ProQR Therapeutics, up from -$20375.3 in the prior quarter.
  • Over the last five years, Change in Taxes for PRQR hit a ceiling of $215377.5 in Q2 2024 and a floor of -$421026.6 in Q4 2024.
  • Historically, Change in Taxes has averaged -$10055.9 across 5 years, with a median of $2592.3 in 2024.
  • The widest YoY moves for Change in Taxes: up 678.34% in 2022, down 268.55% in 2022.
  • Tracing PRQR's Change in Taxes over 5 years: stood at $25167.4 in 2021, then soared by 678.34% to $195887.5 in 2022, then tumbled by 188.43% to -$173226.3 in 2023, then crashed by 143.05% to -$421026.6 in 2024, then skyrocketed by 110.23% to $43069.6 in 2025.
  • Business Quant data shows Change in Taxes for PRQR at $43069.6 in Q4 2025, -$20375.3 in Q2 2025, and -$421026.6 in Q4 2024.